Articles tagged "Renal failure"

2019 American Transplant Congress
Galectin-3 and Long-Term Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study
C. G. Sotomayor¹, C. A. Keyzer¹, J. L. Anderson¹, R. O. Gans², I. M. Nolte³, M. H. de Borst¹, S. P. Berger¹, G. J. Navis¹, R. A. de Boer⁴, S. J. Bakker¹
¹Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands, ²Department of Internal Medicine, University Medical Center Groningen, Groningen, Netherlands, ³Department of Epidemiology, University Medical Center Groningen, Groningen, Netherlands, ⁴Department of Cardiology, University Medical Center Groningen, Groningen, Netherlands
*Purpose: Galectin-3 has been associated with renal fibrosis and decline of renal function. We aimed to determine the association of galectin-3 with long-term risk of…
2019 American Transplant Congress
Should Preceding Solo-Kidney Transplantation for Patients with Type 1 Diabetes with End Stage Renal Failure Be Carried Out?
T. Ito, T. Kenmochi, K. Kurihara, A. Kawai, N. Aida
Transplantation and Regenerative Medicine, Fujita Health University, School of Medicine., Aichi, Japan
*Purpose: Patients with type 1 diabetes with end stage renal failure are indicated for SPK, but if the family requests a renal donation and living…
2019 American Transplant Congress
Racial Variation in ESRD Diagnosis Patterns among Prior Living Kidney Donors on the OPTN Kidney Waiting List
J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, C. Custer¹, R. Brown³, D. Stewart¹
¹Research, UNOS, Richmond, VA, ²Office of the Chief Medical Officer, UNOS, Richmond, VA, ³Organ Center, UNOS, Richmond, VA
*Purpose: We studied End Stage Renal Disease diagnosis patterns among prior living kidney donors (PLDs) who received candidate PLD priority on the OPTN kidney waiting…
2019 American Transplant Congress
Renal Cell Carcinoma in Dialysis Patients: Criteria for Transplant Wait List Inclusion
D. B. Laskar¹, J. Zeng¹, S. Sharma², M. T. Smith Jr³, A. D. Nicastri¹, D. Levitan⁴, R. Maglantay¹, D. John³, S. R. Gottesman¹
¹Pathology, SUNY Downstate Medical Center, Brooklyn, NY, ²Transplant Surgery, NYP/Columbia University Medical Center, New York, NY, ³Surgery, SUNY Downstate Medical Center, Brooklyn, NY, ⁴Pathology & Laboratory Medicine, NYP/Weill Cornell Medical Center, New York, NY
*Purpose: End-stage renal disease (ESRD) patients on long-term hemodialysis have a higher incidence of renal cell carcinoma (RCC) in their native kidneys than the general…
2019 American Transplant Congress
Assessing Pressure to Donate among Potential Living Kidney Donors
D. R. Helfer¹, J. Stanton², E. A. King¹, A. K. Eno¹, J. M. Ruck¹, A. A. Shaffer¹, A. G. Thomas¹, M. M. Waldram¹, A. M. Cameron¹, J. Kahn¹, L. Erby¹, M. L. Henderson¹, D. L. Segev¹, J. M. Garonzik Wang¹
¹Johns Hopkins University, Baltimore, MD, ²East Carolina University, Greenville, NC
*Purpose: In the setting of ongoing methods to increase living donation, including novel methods that harness the power of social media, it is imperative that…
2019 American Transplant Congress
Early Impact of the New United Network for Organ Sharing Simultaneous Liver-Kidney Transplantation Allocation Policy: Improved Standardization but Similar Utilization
G. Cullaro¹, E. C. Verna², J. C. Lai¹
¹UCSF, San Francisco, CA, ²Columbia University, New York, NY
*Purpose: In an effort to standardize SLKT utilization, UNOS/OPTN implemented a new SLKT policy on August 10th, 2017. We aimed to characterize the early impact…
2019 American Transplant Congress
The Use of Native Kidney Biopsy to Predict Renal Dysfunction Following Liver Transplantation
D. O. Walls¹, L. Muraveika¹, M. B. Palmer², D. L. Sawinski³, B. J. Keating¹, P. L. Abt¹
¹Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, ²Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA, ³Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Acute and chronic kidney injury are a common occurrence for patients with end-stage liver disease and are associated with significant morbidity and mortality. We…
2019 American Transplant Congress
Using an Electronic Medical Record Tool to Document Transplant Option Discussions among Patients with EGFR ≤ 20 mL/min/1.73m²
A. Yishak¹, R. R. Brentari², R. M. Love La Londe³, E. Clark⁴, E. Clark⁴, J. Sun⁵, S. Vupputuri⁶
¹Nephrology, MAPMG, Mc Lean, VA, ²KP National Transplant Service, Oakland, CA, ³KP National Transplant Services, Oakland, CA, ⁴KP National Transplant Services, silver spring, MD, ⁵KP, Rockville, MD, ⁶MAPRI, MAPMG, Rockville, MD
*Purpose: The purpose of this study, in a large integrated health system, was to improve: 1) the documentation of transplant option discussions by providers among…
2019 American Transplant Congress
Evaluation of Delayed Renal Allograft Function after DCD with New Biomarkers in Donor Blood
X. Zheng
Beijing Chaoyang Hospital, Capital Medical University, Beijing, China
*Purpose: To explore the relationship between new biomarkers in donor blood and delayed graft function (DGF) after DCD kidney transplantation, and to evaluate the clinical…
2019 American Transplant Congress
Reevaluating Cut-Off Points for the Expansion of Deceased Donor Criteria for Kidney Transplantation in Japan
Y. NAKAGAWA¹, M. Masahiro², M. Tasaki², K. Saito³, K. Takahashi⁴
¹Department of Urology,, Uonuma Kikan Hospital, Niigata, Japan, ²Department of Regenerative and Transplant Medicine, Niigata University, Niigata, Japan, ³Department of Urology,, Niigata University, Niigata, Japan, ⁴Department of Urology,, Otsukadai Clinic, Tokyo, Japan
*Purpose: A shortage of donors poses a serious problem for organ transplantation around the world. In response, the concept of the Expanded Criteria Donor (ECD)…